- Trials with a EudraCT protocol (55)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
55 result(s) found for: Catecholamines.
Displaying page 1 of 3.
EudraCT Number: 2018-000191-15 | Sponsor Protocol Number: CORO-RYC-001 | Start Date*: 2018-06-13 | |||||||||||
Sponsor Name:IRICYS- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal | |||||||||||||
Full Title: Effectiveness and Safety on Cardiac Frecuency Control With Ivabradine on the Cardiogenic Shock. (ES-FISH) | |||||||||||||
Medical condition: Cardiogenic Shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004867-19 | Sponsor Protocol Number: v1330032015 | Start Date*: 2015-02-24 |
Sponsor Name:Clinic for General Anesthesiology, Intensive Care and Pain Management | ||
Full Title: Perioperative fluid management in patients receiving major abdominal surgery – Effects of normal saline versus an acetate buffered balanced infusion solution on the necessity of catecholamines for ... | ||
Medical condition: hemodynamic stability of patients undergoing major surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001908-23 | Sponsor Protocol Number: 13-5-23-9-3-8-15 | Start Date*: 2008-06-20 |
Sponsor Name:Rigshospitalet, Department of Clinical Pharmacology | ||
Full Title: A randomised, double blinded, crossover study of the influence of Metoprolol on exercise induced elevation of catecholamines in healthy subjects. | ||
Medical condition: The medical condition to be investigated is heart failure, but this specific study is made on healthy volunteers to investigate the influence of metoprolol on exercise induced elevation of catechol... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004198-10 | Sponsor Protocol Number: SCT-Cpx-003 | Start Date*: 2012-03-22 |
Sponsor Name:Swiss Cardio Technologies AG | ||
Full Title: A Single-Centre, Single Blind, Randomized, Active-Controlled Phase III Non-Inferiority Study to Investigate the Safety and Efficacy of the Cardioplegic Solution Cardioplexol when used during a Ca... | ||
Medical condition: Medical conditions necessitating an elective surgical coronary artery bypass grafting (CABG) and/or a valve repair/replacement. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016954-42 | Sponsor Protocol Number: SCT-Cpx-001 | Start Date*: 2010-10-28 |
Sponsor Name:Swiss Cardio Technologies AG | ||
Full Title: Randomized Clinical Safety and Efficacy Investigation of the Swiss Cardio Technologies Cardioplexol Solution in comparison with Buckberg Solution | ||
Medical condition: Medical conditions necessitating an elective surgical coronary artery bypass grafting (CABG) and/or a valve repair/replacement. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001702-30 | Sponsor Protocol Number: 200175 | Start Date*: 2022-02-08 |
Sponsor Name:APHP | ||
Full Title: « Use of Levosimendan as treatment of aneurysmal SubArachnoid Hemorrhage » | ||
Medical condition: subarachnoid hemorrhages of aneurysmal origin (HSAa) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002603-13 | Sponsor Protocol Number: 200601 | Start Date*: 2006-10-24 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Is treatment with octreotide effective in patients with head-and-neck paraganglioma? | ||
Medical condition: Patients with head-and-neck paraganglioma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-001654-15 | Sponsor Protocol Number: NL53018.015.15 | Start Date*: 2015-10-15 |
Sponsor Name:Máxima Medisch Centrum | ||
Full Title: Intrauterine resuscitation during term labor by maternal hyperoxygenation. | ||
Medical condition: Fetal distress during the second stage of labor. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024225-20 | Sponsor Protocol Number: 301110_PALANCE | Start Date*: 2014-08-22 |
Sponsor Name:University Hospital Munich, Germany | ||
Full Title: The impact of phosphate balanced cristalloid infusion on acid-base homeostastis | ||
Medical condition: This study aims to investigate a new crystalloid fluid therapy regime for the perioperative setting providing stable fluid and acid-base homeostasis in the patient. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004123-67 | Sponsor Protocol Number: PHRCI2012/CHOCMSC-GIBOT/SKJ | Start Date*: 2021-04-30 |
Sponsor Name:Centre Hospitalier Régional Universitaire de Nancy | ||
Full Title: CHOCMSC Study Effects of mesenchymal stem cells administration on organ failure during septic shock: Phase II randomized placebo-controlled study | ||
Medical condition: septic shock | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004674-49 | Sponsor Protocol Number: LEVOHLM | Start Date*: 2007-12-28 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: Levosimendan vor Herz-Lungen-Maschine bei Coronary artery bypass graft-Operationen | ||
Medical condition: The drug Levosimendan / Simdax (R) will be investigated in patients undergoing coronary artery bypass graft operations. The study population will be patients with impaired myocardial function as st... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-006861-18 | Sponsor Protocol Number: 20061212 | Start Date*: 2007-03-26 |
Sponsor Name:Department of Cardiology | ||
Full Title: Comparison between beta-adrenergic blockers and angiotensin II receptor antagonists for the treatment of late hypertension in patients with repaired aortic coarctation | ||
Medical condition: Aortic coarctation and late hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002096-16 | Sponsor Protocol Number: 01/04 | Start Date*: 2005-05-23 |
Sponsor Name:Universitätskinderklinik Innsbruck | ||
Full Title: Effect of plasma volume expansion with hydroxy-ethyl-starch (HES) 130/0.4 or crystalloids on interstitial fluid accumulation and blood pressure in newborn infants with arterial hypotension | ||
Medical condition: Arterial hypotension | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-002311-10 | Sponsor Protocol Number: SCT-Cpx-004 | Start Date*: 2018-10-09 |
Sponsor Name:Swiss Cardio Technologies AG | ||
Full Title: A multi-center, open label, single group, observational study to investigate the effects of training on the administration of Cardioplexol (TM) | ||
Medical condition: Medical conditions with the need for an elective surgical coronary artery bypass grafting (CABG) and/or a valve repair/replacement . | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003714-68 | Sponsor Protocol Number: 1744/2017 | Start Date*: 2017-11-15 | ||||||||||||||||
Sponsor Name:Medical University of Vienna | ||||||||||||||||||
Full Title: Effect of Supplemental Oxygen on Perioperative Brain Natriuretic Peptide Concentration in Cardiac Risk Patients - A prospective randomized clinical trial | ||||||||||||||||||
Medical condition: Evaluation of the effect of 80% versus 30% supplemental oxygen administration during major abdominal surgery on postoperative brain natriuretic peptide concentration. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-006135-12 | Sponsor Protocol Number: BalaCriCo | Start Date*: 2008-12-19 |
Sponsor Name:Charité- University Medicine Berlin | ||
Full Title: Balanced crystalloids versus balanced colloids within a goal-directed hemodynamic protocol in patients undergoing gynaecological tumor resection. Balancierte Kristalloide versus balancierte Kolloi... | ||
Medical condition: The drugs Jonsteril and Volulyte6% will be investigated in female patients undergoing a tumor reduction operation. The study population will be female patients with metastatic ovarian carcinoma. Th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001827-41 | Sponsor Protocol Number: PI2020_843_0094 | Start Date*: 2021-06-11 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Evaluation of the early use of norepinephrine in major abdominal surgery on postoperative organ dysfunction | ||
Medical condition: major abdominal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-006129-17 | Sponsor Protocol Number: 178S11PF | Start Date*: 2012-05-18 |
Sponsor Name:PASCOE Pharmazeutische Präparate GmbH | ||
Full Title: A randomized, double blind, placebo-controlled pilot study on the efficacy of Passiflora incarnata L. in an acute stressful situation | ||
Medical condition: Since only healthy volunteers will be included in this study, there is no medical condition to be examined. The indication for PASCOFLAIR® is nervous restlessness, a subclinical state of stress-sen... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004622-14 | Sponsor Protocol Number: LPS_concmed_controlled | Start Date*: 2013-02-01 |
Sponsor Name:Radboud University Nijmegen Medical Centre | ||
Full Title: Concentration/meditation as a novel means to limit inflammation: a randomized controlled pilot study | ||
Medical condition: Possibe future indications: inflammatory conditions in general, auto-immune diseases | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002671-34 | Sponsor Protocol Number: PI20208430057 | Start Date*: 2020-12-04 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity: an open label prospective randomized study | ||
Medical condition: septic shock with hypercontractlity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
